Cognitive Dysfunction, Cognitive Disorder
12
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (12)
Serum Sulfate and Brain Function in Diabetic Encephalopathy
HOBSCOTCH-YOUTH and Young Adults
MW151 and Whole-brain Radiotherapy in Patients With Intracranial Metastases
Effects of Adaptive Difficulty Computerized Cognitive Training on Cognitive Function Improvement in Older Adults With Mild Cognitive Impairment
Evaluation of Clinical Efficacy and Mechanism of Hand Jing-Well Acupoint Transcutaneous Electrical Stimulation in Improving Post-Stroke Cognitive Impairment
Cognitive-Based Balance Rehabilitation in Parkinson's Disease: Virtual Reality vs. Dual Task
China-NINE Cohort：Neuroimmune Network in Elderly / Neurodegeneration
DIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse Community
A Study of Sabroxy™ (Oroxylum Indicum Extract) for Improving Cognitive Function in Adults With Mild Memory Concerns
Aβ PET and Tau PET Imaging in the Diagnosis and Progression Assessment of Alzheimer's Disease
INSIDE: Intervention in Nutritional Supplementation to Improve Cognitive Decline in Elderly.
The Effect of Two Different Modes of Anaesthesia Mainantance on Postoperative Delirium